Epidemiological characteristics of leprosy from 2000 to 2019 in a state with low endemicity in southern Brazil^☆

Abstract

Background

Leprosy is an infectious and contagious disease caused by Mycobacterium leprae and is mainly characterized by lesions in the skin and peripheral nerves. In Brazil, it is a public health problem due to its high endemicity. However, the state of Rio Grande do Sul presents low endemicity of this disease.

Objective

To characterize the epidemiological profile of leprosy in the state of Rio Grande do Sul from 2000 to 2019.

Methods

This was a retrospective observational study. Epidemiological data were collected from the Notifiable Diseases Information System (SINAN, Sistema de Informação de Agravos de Notificação).

Results

Among the 497 municipalities in the state, 357 (71.8%) registered cases of leprosy in the assessed period, with an average of 212 (81.5%) new cases per year. The average detection rate was 1.61 new cases per 100,000 inhabitants. The male sex was predominant (51.9%) and the mean age was 50.4 years. Regarding the epidemiological clinical profile; 79.0% of the patients were multibacillary; 37.5% presented the borderline clinical form; 16% had grade 2 physical disability at diagnosis and bacilloscopy was positive in 35.4% of cases. As for treatment, 73.8% of the cases were treated with the standard multibacillary therapeutic regimen.

Study limitations

There were missing/inconsistent data in the database available.

Conclusions

The findings observed in this study indicate that the state presents a low endemicity profile of the disease and these results can support adequate health policies relevant to the reality of Rio Grande do Sul, inserted in a national scenario of highly endemic leprosy.

Keywords
Epidemiology; Health profile; Leprosy; Prevalence

Introduction

Leprosy is an infectious disease caused by Mycobacterium leprae, which is characterized mainly by lesions in the skin and peripheral nerves. As the disease progresses, it can lead to damage to other organs such as the liver, kidneys, lymph nodes, testes, eyes, and lymph nodes.¹,²

The first records of leprosy in history were made in 600 BC in China and its first clinical description was made in the 3^rd century BC.³,⁴ Leprosy is a disease with worldwide distribution that still causes prejudice and psychological suffering, and the patient is viewed with disapproval by the population.¹-⁴ Since the introduction of multidrug therapy with the possibility of a cure in 1982, there has been a significant reduction in the number of cases.⁴ The World Health Organization (WHO), in 1991, at the 44^th session of the World Health Assembly, approved a resolution that established as a goal the elimination of leprosy as a public health problem by the year 2000. For the goal to be accomplished, it was necessary for the disease prevalence to be less than one case per 10,000 inhabitants.⁵,⁶

India is the country with the highest number of leprosy cases, with Brazil ranking second, due to high endemicity.⁴,⁷,⁸ There were 301,638 new cases in the country from 2010 to 2019.⁹ The detection rate decreased by 37% over time and, in 2019, it was 13.23 cases per 100,000 inhabitants. In the Northern, Northeastern, and Midwestern regions, the disease is of high endemicity, while the Southern and Southeastern regions present a medium level of endemicity, with Rio Grande do Sul and Santa Catarina being classified as states with low endemicity.⁹ For the classification of endemicity, one must consider the following rates per 100,000 inhabitants: > 40.00 cases (hyperendemicity); 20.00 to 39.99 cases (very high endemicity); 10.00 to 19.99 cases (high endemicity); 2.00 to 9.99 cases (medium endemicity) and < 2.00 cases (low endemicity).²

According to the last census in 2010, the state of Rio Grande do Sul has a population of 10,693,929 people, distributed into 497 municipalities, with around 15% of individuals residing in rural areas, and with a human development index of 0.746.¹⁰ Rio Grande do Sul, during the period of 2010 to 2019, remained a state with low endemicity, recording an average of 1.16 cases per 100,000 inhabitants.² The classification of low endemicity should not be considered a comfortable situation meaning resolution of the disease; other parameters must be observed such as the occurrence of cases in children under 15 years of age,¹¹,¹² clinical form of the disease, percentage of physical disability degree at diagnosis and percentage of cured cases.² It is also necessary to evaluate the health care network for people with leprosy, its coverage, and capacity for diagnosis and treatment, evaluation of contacts, and follow-up after treatment when necessary. Currently, services are offered in response to demand and, therefore, diseases that are apparently under control and with lower occurrence rates are ultimately neglected in government policies.

The study aimed to characterize the epidemiological profile of leprosy in the state of Rio Grande do Sul and correlate elements that contribute to bringing public policies closer to the reality of the present situation in a state with low endemicity of leprosy.

Methods

This was a retrospective observational study, carried out in the State of Rio Grande do Sul (32°1′60″ South, 52°5′55″ West), located in southern Brazil, from 2000 to 2019.

The epidemiological data were collected from the Notifiable Diseases Information System (SINAN, Sistema de Informação de Agravos de Notificação) in July 2020, which was made available by the State Health Surveillance Center of Rio Grande do Sul. Information on the state population was obtained through the 2010 Demographic Census, the last one carried out to date by the Brazilian Institute of Geography and Statistics (IBGE, Instituto Brasileiro de Geografia e Estatística). The detection and prevalence rates presented herein followed the pattern recommended by the Ministry of Health, which are the detection coefficient per 100,000 inhabitants and the prevalence coefficient per 10,000 inhabitants.²

Data processing was carried out through a database in an Excel 365 spreadsheet with sociodemographic indicators (sex, age group, race/skin color, level of schooling, area of residence) and clinical epidemiological indicators (operational classification, clinical classification, entry mode, detection mode, degree of physical disability, bacilloscopy and therapy). To calculate the detection and prevalence rates, according to Ministry of Health guidelines,² only cases classified as “new cases” in the case entry mode were considered. The other sociodemographic and clinical indicators were analyzed in the total number of cases, regardless of the entry mode.

Statistical analyses were performed using the SPSS 26 software. The descriptive statistical measures used were rates, frequency, percentage, mean and standard deviation. The bivariate analyses were performed using the Chi-square test for categorical variables, using a statistical significance level of 5% (two-tailed).

The research project was submitted to the Research Ethics Committee of Hospital de Clínicas de Porto Alegre (CAAE: 31959120.6.0000.5327) and to the Ethics Committee of Escola de Saúde Pública do Rio Grande do Sul (CAAE: 3195120.6.5312), being approved in accordance with Counsels n. 4.075.445 and 4.121.621, respectively, according to Resolutions 466/12 and 510/16 of the National Health Council that regulate research with human beings.

Results

From 2000 to 2019, Rio Grande do Sul presented an average of 212 cases per year, with 81.6% (n = 3,442) being new cases. The average rate of detection of new cases was 1.61 cases per 100,000 inhabitants/year. Among children under 15 years of age, this rate was 0.04 cases per 100,000 inhabitants/year, corresponding, on average, to 2.48% of the total number of new cases in the studied period. The leprosy prevalence rate in the study was always less than one case per 10,000 inhabitants, with an average of 0.16 cases per 10,000 inhabitants (Table 1). Over the period, the average number of new cases classified as multibacillary was 131.2 cases. Thus, on average, 76.2% of the diagnoses performed per year, during the studied period, were multibacillary ones. The rate of visible physical disability degree (Grade 2), already present at the diagnosis, ranged between 0.09 and 0.50 cases per 100,000 inhabitants. On average, the rate was 0.22 cases per 100,000 inhabitants/year (Table 1).

Table 1
Leprosy control indicators in Rio Grande do Sul, according to the Brazilian Ministry of Health, distributed by year, from 2000 to 2019

Reference year	Detection rate (per 100,000 inhabitants)	Detection rate in children under 15 years of age (per 100,000 inhabitants)	Cases in children under 15 years of age (%)	Multibacillary cases	Rate of new cases with grade 2 at diagnosis (per 100,000 inhabitants)	Prevalence rate (per 10,000 inhabitants)
2000	1.80	0.04	2.07	136	0.50	0.18
2001	1.88	0.02	1.00	125	0.16	0.19
2002	2.30	0.07	2.85	176	0.31	0.23
2003	2.20	0.05	2.13	173	0.14	0.22
2004	2.38	0.07	2.76	197	0.22	0.24
2005	2.35	0.04	1.59	202	0.36	0.23
2006	1.89	0.01	0.50	150	0.20	0.19
2007	1.78	0.04	2.11	152	0.28	0.18
2008	1.80	0.01	0.52	135	0.26	0.18
2009	1.57	0.04	2.38	126	0.13	0.16
2010	1.34	0.04	2.80	109	0.09	0.13
2011	1.37	0.03	2.05	113	0.20	0.14
2012	1.45	0.01	0.65	121	0.20	0.14
2013	1.45	0.02	1.29	111	0.18	0.14
2014	1.41	0.03	1.99	116	0.22	0.14
2015	1.10	0.03	2.54	101	0.18	0.11
2016	0.98	0.02	1.90	94	0.17	0.10
2017	1.05	0.07	6.25	98	0.20	0.10
2018	1.10	0.05	4.24	106	0.27	0.11
2019	0.99	0.07	7.55	83	0.20	0.10

The period with the highest number of records in this section occurred from 2000 to 2006, with an average of 226 new cases per year. As of 2007, a downward trend occurred in the number of new cases, to below 200 new cases/year, with an average of 162.6 new cases/year until 2014, representing a reduction of 38.4%. From 2015 to 2019, this decline increased to 50.5%, compared to the period between 2000 and 2006. From 2006 onwards, there was some stability in the registration of new cases, which remained at an average of 112 cases per year until 2019. There was a predominance of multibacillary cases, a clinical form present in at least 69% of cases/year (Fig. 1).

Figure 1
Numbers of new cases of leprosy notified from 2000 to 2019, and multibacillary cases in the same period, according to year, in the state of Rio Grande do Sul, Brazil

Among a total of 497 municipalities, 357 (71.9%) recorded cases of leprosy. The municipalities with the highest number of cases among their residents were, in descending order, Porto Alegre (n = 342), São Borja (n = 212), and Uruguaiana (n = 193; Fig. 2).

Figure 2
Georeferencing of notified leprosy cases from 2000 to 2019, according to the place of residence, in the state of Rio Grande do Sul, Brazil. Source: the authors

The male sex was predominant (51.9%) and the overall mean age was 50.4 years (SD = 16.2), and, regarding this variable, there was no difference in relation to sex. When skin color was analyzed, whites were predominant (81.7%). Illiteracy rate was 7.1%, where the noteworthy fact was that 72.7% of patients had not finished Elementary School at the time of the diagnosis. Most patients lived in urban areas (84.3%; Table 2).

Table 2
Sociodemographic profile of leprosy from 2000 to 2019, according to sex, in the state of Rio Grande do Sul, Brazil

Characteristics	Sex		Total	%a
	Female	Male	n = 4233
Age group
0‒14	34 (0.8)	43 (1.1)	77	1.9
15‒29	219 (5.3)	234 (5.6)	453	10.9
30‒49	623 (15.0)	664 (16.0)	1287	31.0
50‒60	579 (14.0)	591 (14.2)	1170	28.2
61‒79	495 (11.9)	581 (14.0)	1076	25.9
80 or older	50 (1.2)	38 (0.9)	88	2.1
Missing data	‒	‒	82	‒
Race/Skin color
White	1558 (41.0)	1544 (40.7)	3102	81.7
Black	76 (2.0)	110 (2.9)	186	4.9
Brown	184 (4.8)	283 (7.5)	467	12.3
Yellow	11 (0.2)	16 (0.4)	27	0.7
Indigenous	6 (0.2)	9 (0.2)	15	0.4
Missing data	‒	‒	436	‒
Level of schooling
Illiterate	117 (3.3)	137 (3.8)	254	7.1
1st to 4th grade of Elementary School	530 (14.8)	614 (17.1)	1144	31.9
5th to 8th grade of Elementary School	581 (16.2)	627 (17.5)	1208	33.7
Complete Elementary School	87 (2.4)	107 (3.0)	194	5.4
Incomplete High School	164 (4.6)	181 (5.0)	345	9.6
Complete High School	106 (2.9)	74 (2.1)	180	5.0
Incomplete Higher Education	23 (0.6)	26 (0.8)	49	1.4
Complete Higher Education	133 (3.7)	80 (2.2)	213	5.9
Missing data	‒	‒	646	‒
Area of residence
Urban	1680 (42.4)	1664 (42.0)	3344	84.4
Rural	265 (6.7)	310 (7.8)	575	14.5
Peri-urban	17 (0.4)	22 (0.6)	39	1.0
Missing data	‒	‒	557	‒

• ^a
  Percentages were calculated disregarding missing data.

Most leprosy cases in the assessed period were classified as multibacillary (79.0%), with males accounting for 43.4% of these cases. The predominant clinical form was borderline (37.5%), with predominance of females (19.2%). The mode of entry of cases, in almost all of them (81.6%), comprised new cases. Recurrence cases represented 7.8% of the sample, and the method of detection was referral in 52.6% of them. The degree of visible physical disability was already Grade 2 in 16% of the cases at diagnosis, and males were the most affected. Bacilloscopy was performed in 68% of the diagnosed cases, with a positive result in 35.4% of the tests (Table 3).

Table 3
Epidemiological clinical profile of leprosy from 2000 to 2019, according to sex, in the state of Rio Grande do Sul, Brazil

Characteristics	Sex		Total	%a
	Female n (%)	Male n (%)	n = 4233
Operational classification
Paucibacillary	523 (12.4)	359 (8.6)	882	21.0
Multibacillary	1496 (35.6)	1822 (43.4)	3318	79.0
Missing data	‒	‒	33	‒
Clinical form
Indeterminate	219 (5.9)	169 (4.6)	388	10.5
Tuberculoid	313 (8.5)	231 (6.2)	544	14.7
Borderline	713 (19.2)	680 (18.3)	1393	37.5
Lepromatous	534 (14.4)	851 (22.9)	1385	37.3
Missing data	‒	‒	525	‒
Therapeutic regimen
Multidrug therapy 6 doses MDT/PB	510 (12.5)	344 (8.2)	854	20.4
Multidrug therapy 12 doses MDT/MB	1393 (33.2)	1703 (40.6)	3096	73.8
Substitute regimens	116 (2.8)	130 (3.0)	246	5.8
Missing data	‒	‒	37	‒
Case entry mode
New case	1690 (40.1)	1752 (41.5)	3442	81.6
Recurrence	149 (3.5)	179 (4.3)	328	7.8
Other modes	192 (4.6)	255 (6.0)	447	10.6
Missing data	‒	‒	16	‒
Case detection mode
Referral	870 (24,8)	976 (27,8)	1846	52,6
Spontaneous demand	597 (17,0)	614 (17,5)	1211	34,5
Collective examination	12 (0,4)	22 (0,6)	34	1,0
Examination of contacts	216 (6,1)	136 (3,9)	352	10,0
Other modes	30 (0,9)	35 (1,0)	65	1,9
Missing data	-	-		-
Assessment of the degree of physical disability
Grade zero	1016 (26,3)	911 (23,5)	1927	49,8
Grade 1	622 (16,0)	700 (18,2)	1322	34,2
Grade 2	252 (6,4)	370 (9,6)	622	16,0
Missing data	‒	‒	362	‒
Bacilloscopy
Negative	379 (18,1)	302 (14,5)	681	32,6
Positive	261 (12,5)	477 (22,9)	738	35,4
Not performed	311 (14,9)	358 (17,1)	669	32,0
Missing data	‒	‒	2145	‒

• ^a
  Percentages were calculated disregarding missing data.

In the bivariate analysis, an association (p ≤ 0.001) was found between multibacillary classification and physical disability Grade 2, with the same fact being verified for the borderline and lepromatous clinical forms (p ≤ 0.001). Regarding bacilloscopy, a significant association (p ≤ 0.001) was also found with physical disability Grade 2 (Table 4).

Table 4
Cross-quantitative distribution, associating the characteristics: operational classification, clinical forms and bacilloscopy with degree of physical disability of leprosy, from 2000 to 2019, in the state of Rio Grande do Sul, Brazil

Characteristicsa	Degree of physical disability		p -valued
	Grade 0 or 1 (n = 3237)	Grade 2 (n = 622)
	n (%)	n (%)
Operational classification			<0.001
Paucibacillary	779 (24.0)	33 (5.3)
Multibacillary	2458 (76.0)	589 (94.7)
Clinical formb			<0.001
Indeterminate	348 (12.0)	11 (1.9)
Tuberculoid	467 (16.1)	43 (7.4)
Borderline	1097 (38.0)	221 (38.2)
Lepromatous	979 (33.9)	303 (52.4)
Bacilloscopyc			<0.001
Negative	528 (51.7)	103 (38.6)
Positive	494 (48.3)	164 (61.4)

• ^a
  Total data may vary depending on the possibility of missing data and non-response.
• ^b
  Clinical form: no visible physical disabilities n = 2891; with visible physical disabilities n = 578.
• ^c
  Bacilloscopy: no visible physical disabilities n = 1022; with visible physical disabilities n = 267.
• ^d
  Chi-Square Test.

Discussion

Rio Grande do Sul is a state with low endemicity for leprosy. However, in the assessed period, there was at least one recorded case in more than 70% of its municipalities. With regard to sex, other studies also reported the predominance of males, with a small difference in percentage.¹³,¹⁴ A study was carried out in Rwanda, Central Africa, with a smaller number of cases (77 patients), which showed that 75% of the patients were male.¹⁵ However, other authors found a predominance of females in their analysis,¹⁶-¹⁸ indicating that there is sex variation according to time and place. Regarding age groups, there was a prevalence of cases between 30 and 60 years (59.2% of cases), which constitute the economically active age groups. The predominance of cases in these age groups, between 30 and 60 years old, as well as in persons white skin color, is in agreement with data found in the literature.¹⁶,¹⁹-²¹

The predominance of the white skin color in the present study should not be considered relevant because these data reflect only the predominant skin color in the population of the southern region of Brazil. In Rio Grande do Sul, according to the Brazilian Institute of Geography and Statistics (IBGE, Instituto Brasileiro de Geografia e Estatística), 85.9% of respondents self-declared to be white in 2013. Therefore, this skin color is expected to predominate among leprosy cases in the state.²² In other studies, the predominant skin color was brown, while the area of residence and economically active age group were similar to those found in the present data.²³-²⁶

The next age group with the highest number of cases was between 61 and 79 years (25.9%), which may indicate long disease duration and late diagnosis. In this age group, leprosy may be associated with comorbidities, and it is necessary to observe the occurrence of other diseases and drug interactions.²⁶,²⁷

As for the level of schooling, not having finished Elementary School was similar to that found in other studies.¹⁶,¹⁹-²¹,²³ As for the area of residence, 84.3% of patients lived in urban areas, data that corroborate the population characteristics of the state of Rio Grande do Sul, where only 15% of people live in rural areas.¹⁰ The sociodemographic variables are similar in different regions of Brazil, with a predominance of males, economically active age group, low level of schooling, and urban residence, with only a certain variation in skin color depending on the region.¹⁶,¹⁹-²¹,²³

There was a predominance of cases classified as multibacillary, and only 21% of cases were paucibacillary, corroborating the literature data.¹⁶,¹⁹,²¹ However, in endemic regions, some studies show that most cases are classified as paucibacillary.²⁰,²⁸ The operational classification showed to be consistent data in SINAN, as it was absent in only 0.7% (n = 33) of the records. However, in the present study, indeterminate and tuberculoid clinical forms, which are included in the paucibacillary classification, represented 25.2% of the cases when combined, while the total number of cases classified as paucibacillary was only 21.0%. This demonstrates inconsistency in data recording. This occurrence can be explained in part by substitutive treatments, which were carried out in 5.8% of cases in the total sample. However, it was observed that treatment changes can occur in all clinical forms of the disease.²⁸,²⁹ Other possibilities are the inadequate transposition of information to SINAN and errors in filling out the data by the professionals who performed the diagnosis. SINAN also has limitations regarding the standardization of records, duplication of cases, and lack of information. Nevertheless, it is an important source of information for notifiable diseases in Brazil. Data inconsistencies are difficult to verify, considering the model of the present study.

As for the therapeutic regimen, the standard multibacillary regimen was carried out in 73.8% of the cases, and for 5.8% of the leprosy cases, the substitutive therapeutic regimen was indicated at the beginning of treatment, which may indicate previous comorbidities, low weight and previous intolerance to one of the multidrug therapy medications. However, it was not possible to define the reason for choosing the substitutive treatment, because SINAN does not collect this type of information. In other studies, the main drug that results in changes in the standard treatment is dapsone, which has side effects such as hemolytic anemia, liver alterations, and gastrointestinal problems, usually manifesting in the first four months of treatment.²⁹-³¹

Regarding the case entry mode, there was a low number of cases diagnosed by evaluation of contacts (10.0%), however there are studies indicating that, for one index case, there is a chance of up to a 2.8-fold possibility of diagnosing new cases among contacts.³²,³³ The lack of evaluation of contacts is one of the factors that may explain the high number of cases with a degree of physical disability already established at the diagnosis (50.2%), an important indicator of late diagnosis and risks for disabilities and sequelae, both physical and emotional.³,¹⁹,²⁰,²⁵

Bacilloscopy was performed in most cases (68%) which had this information reported, and its main purpose is to determine leprosy classification. When positive, it indicates a multibacillary case, but if negative, it does not allow the diagnosis to be discarded, and the test is not mandatory for disease diagnosis.² Moreover, some multibacillary patients do not have a positive bacilloscopy, even when naïve for treatment. Cavalcanti et al. showed that agreement between bacilloscopy and the operational classification occurred in only 30% of the cases; however, even so, the test positively contributes to the identification of borderline cases. In these cases, the use of the clinical classification alone, according to the number of lesions, would lead multibacillary cases to being misclassified and treated as paucibacillary ones.²,³⁴ Bacilloscopy also helps monitoring at the end of treatment, allowing the comparison of the bacillary index at the beginning of treatment and the end.² It is important to emphasize that, in the state of Rio Grande do Sul, this test is only performed at the state reference center for leprosy, the Sanitary Dermatology Outpatient Clinic, located in Porto Alegre.

Over the 20 year period of assessment, the epidemiological behavior of leprosy in the state of Rio Grande do Sul showed low endemicity, with the exception of the period between 2002 and 2005. From 2006 onwards, the annual detection rate was always lower than two cases per 100,000 inhabitants,²,³⁵ and the prevalence rate in this period was always lower than one case per 10,000 inhabitants. Thus, the magnitude of leprosy was low, and these data suggest disease stability behavior during the studied period, associated with the disease behavior in children under 15 years of age, with an average of 0.04 cases per 100,000 inhabitants.² However, it is necessary to assess the rate of physical disability degree and the number of multibacillary cases, which may indirectly indicate disease transmission and early diagnosis.²,³⁶,³⁷

The association (p < 0.001) of the multibacillary operational classification with the physical disability Grade 1 or 2 suggests that multibacillary patients are more likely to develop a certain degree of physical disability and that early diagnoses, in the paucibacillary forms, constitute a form of protection against the onset of these disabilities.³⁸-⁴⁰ In the present study, 94.7% of cases with Grade 2 physical disability at the diagnosis were multibacillary cases, suggesting late diagnosis, the possibility of continuity of disease transmission, and the possibility of reactive outbreaks or sequelae.²⁴,³⁸ It is also emphasized that Rio Grande do Sul, according to data from the Ministry of Health, is the state that has the highest rate of physical disability Grades 1 and 2, confirming late diagnosis in the state.⁸,⁹

The association (p < 0.001) between positive and Grade 2 physical disability highlights that the combination of these two factors at the diagnosis can be decisive for treatment with episodes of reactional outbreaks and physical disability or sequelae.⁴¹,⁴² Physical disabilities and sequelae lead to prejudice and social distancing, which increases the possibility of treatment abandonment and/or the need for post-discharge follow-up.³

Conclusion

According to the clinical-epidemiological profile of leprosy in the period of 2000 to 2019, Rio Grande do Sul is a state with low endemicity. However, in the presence of other health demands such as tuberculosis, dengue, hepatitis, and HIV/AIDS, leprosy goes unnoticed by public policies. There is no appropriate care network, as well as regionalized centers for investigation, diagnosis, and treatment of the disease, with only one referral center in the state of Rio Grande do Sul.

In this context, a high number of multibacillary cases with a degree of physical disability already present at diagnosis, positive bacilloscopy, and a low number of leprosy diagnoses in the assessed contacts were observed. Additionally, the high number of diagnoses with a visible degree of disability (Grade 2) and multibacillary cases may suggest the existence of unknown cases in the state, which, in a way, are expected data for locations with low endemicity or undergoing disease elimination. A positive point observed in the present study was the reduced number of leprosy cases in children under 15 years of age, which is an important indicator to measure the level of disease endemicity listed by the Brazilian Ministry of Health.

It is necessary to broaden the discussion of the number of cases identified per year, the existence of unknown cases, the lack of knowledge about the disease by health professionals, and the lack of information in the community about the disease, aiming to strengthen the self-esteem of leprosy patients and raise awareness of public health managers regarding actions aimed at seeking visibility of the disease.

Carrying out epidemiological profiles in regions with low endemicity allows expanding discussions on late diagnosis, physical disabilities, and self-care, especially after diagnosis and treatment, making it possible to know the behavior of the disease and its problems.

Regarding diseases that have heterogeneous prevalence between regions, such as leprosy, it is known that locations with higher incidence and prevalence rates are the focus of actions and attention from the national leprosy control program.

It is the duty of public health researchers to draw attention to this disease, which is part of the group of neglected diseases and which cannot be disregarded as a public health problem in the state of Rio Grande do Sul. It is hoped that the results of the present study will support adequate health policies and public strategies relevant to the reality of low endemicity in Rio Grande do Sul, inserted in a Brazilian scenario of high endemicity.

• Financial support
  None declared.

• ☆
  Study conducted at the Department of Sanitary Dermatology, Sanitary Dermatology Outpatient Clinic, State Health Secretariat of Rio Grande do Sul and Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.

References

• ¹
  Eidt, LM. Hanseniasis. In: Bonamigo RR, Dornelles SIT, editors. Dermatology in public health environments. A comprehensive textbook, Switzerland: Springer; 2018. p. 61-86.
• ²
  biblioteca.cofen [Internet]. Biblioteca Virtual de Enfermagem. Guidelines for surveillance, care and elimination of leprosy as a public health problem. Technical-operational manual. [cited 2021 Ago 01]. Available from: http://biblioteca.cofen.gov.br/wp-content/uploads/2022/01/diretrizes-vigilancia-atencao-eliminacao-hanseniase.pdf
  » http://biblioteca.cofen.gov.br/wp-content/uploads/2022/01/diretrizes-vigilancia-atencao-eliminacao-hanseniase.pdf
• ³
  Eidt LM. Being leprosy: feelings and experiences. Hansen. Int. 2004;29:21-7.
• ⁴
  Santos MASD, Aquino JLB, Pegas E, Machado ECFA. Analysis of clinical aspects of leprosy patients between 2010-2017 at a reference center in Campinas. An Bras Dermatol. 2020;95:252-4.
• ⁵
  Reibel F, Cambau E, Aubry A. Update on the epidemiology, diagnosis, and treatment of leprosy. Med Mal Infect. 2015;45:383-93.
• ⁶
  apps.who [Internet]. Geneva. World Health Organization. [Resolution No. WHA 44]. Elimination of leprosy: Forty-fourth World Health Assembly, Geneva, 6-16 May 1991: resolutions and decisions, annexes. [cited 2021 Ago 01]. Available from: https://apps.who.int/iris/handle/10665/173858
  » https://apps.who.int/iris/handle/10665/173858
• ⁷
  Ferreira AF, Souza EA, Lima MS, García GSM, Corona F, Andrade ESN, et al. Mortalidade por hanseníase em contextos de alta endemicidade: análise espaço-temporal integrada no Brasil. Rev Panam Saluda Publica. 2019;43:e8
• ⁸
  gov.br [Internet]. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Boletim Epidemiológico. Hanseníase 2020. [cited 2021 Ago 01]. Available from: https://www.gov.br/aids/pt-br/centrais-de-conteudo/boletins-epidemiologicos/2020/hanseniase/boletim-hanseniase-2020-web-1.pdf/view
  » https://www.gov.br/aids/pt-br/centrais-de-conteudo/boletins-epidemiologicos/2020/hanseniase/boletim-hanseniase-2020-web-1.pdf/view
• ⁹
  gov.br [Internet]. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Boletim Epidemiológico. Hanseníase 2021. [cited 2021 Ago 01]. Available from: http://www.aids.gov.br/pt-br/pub/2021/boletim-epidemiologico-hanseniase-2021
  » http://www.aids.gov.br/pt-br/pub/2021/boletim-epidemiologico-hanseniase-2021
• ¹⁰
  cidades.ibge [Internet]. Brasil. Cidades IBGE. Rio Grande do Sul. Panorama. [cited 2021 Set 21]. Available from: https://cidades.ibge.gov.br/brasil/rs/panorama
  » https://cidades.ibge.gov.br/brasil/rs/panorama
• ¹¹
  de Moraes PC, Eidt LM, Koehler A, Pagani DM, Scroferneker ML. Epidemiological characteristics and trends of leprosy in individuals under 15 years of age in a low endemicity state of southern Brazil. Rev Inst Med Trop São Paulo. 2021;63:e80.
• ¹²
  Oppermann K, Salvi CS, Casali HM, de Moraes PC, Cattani CAS, Eidt LM. Epidemiological aspects of leprosy in children under 15 years old, diagnosed in a reference center in southern Brazil, between 2007 and 2017: a trend towards change in the detection of new cases? Hansen Int. 2018;43:e-2366
• ¹³
  Lima AS, Pinto KC, Bona MP, Mattos SM, Hoffmann MP, Mulinari-Brenner FA, et al. Leprosy in a University Hospital in Southern Brazil. An Bras Dermatol. 2015;90:654-9.
• ¹⁴
  Miranzi SS, Pereira LH, Nunes AA. Epidemiological profile of leprosy in a Brazilian municipality, from 2000 to 2006. Rev Soc Bras Med Trop. 2010;43:62-7.
• ¹⁵
  Uwimana I, Bizimungu N, Ingabire F, Mukamukwiye E, Sharangabo O, Ngabonziza SC, et al. Trends in leprosy case detection in Rwanda, 1995-2011: analysis of 17 years of laboratory data. Afr J Lab Med 2017;6:426.
• ¹⁶
  Queirós MI, Ramos AN Júnior, Alencar CH, Monteiro LD, Sena AL, Barbosa JC. Clinical and epidemiological profile of leprosy patients attended at Ceará, 2007-2011. An Bras Dermatol. 2016;91:311-7.
• ¹⁷
  Moreira SC, Batos CJ, Tawil L. Epidemiological situation of leprosy in Salvador from 2001 to 2009. An Bras Dermatol. 2014;89:107-
• ¹⁸
  Albuquerque AR, Silva JVM, Barreto EO, Fraga CAC, Santos WOD, Silva MSMD, et al. Epidemiological, temporal and spatial dynamics of leprosy in a municipality in northeastern Brazil (2008-2017): an ecological study. Rev Soc Bras Med Trop. 2020;53:e20200246.
• ¹⁹
  Martins RJ, Carloni ME, Moimaz SA, Garbin CA, Garbin AJ. Sociodemographic and epidemiological profile of leprosy patients in an endemic region in Brazil. Rev Soc Bras Med Trop. 2016;49:777-80.
• ²⁰
  Gregório V, Pedroza D, Barbosa C, Bezerra G, Montarroyos U, Bonfim C, et al. Predicting the detection of leprosy in a hyperendemic area of Brazil: using time series analysis. Indian J Dermatol Venereol Leprol. 2021;87:651-9.
• ²¹
  Duarte MT, Ayres JA, Simonetti JP. Socioeconomic and demographic profile of leprosy carriers attended in nursing consultations. Rev Lat Am Enfermagem. 2007;15:774-9.
• ²²
  mpsp.mp [Internet]. Brasil. Ministério Público do Estado de São Paulo. Instituto Brasileiro de Geografia e Estatística. Petruccelli JL, Saboia AL (Org.). Características étnico-raciais da população: classificações e identidades. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística - IBGE; 2013. 204 p. [cited 2021 Ago 01]. Available from: http://www.mpsp.mp.br/portal/page/portal/GT_Igualdade_Racial/Artigos_Estudos/Caracter%C3%ADsticas%20%C3%89tnico-Raciais%20da%20Popula%C3%A7%C3%A3o%20Brasileira.pdf
  » http://www.mpsp.mp.br/portal/page/portal/GT_Igualdade_Racial/Artigos_Estudos/Caracter%C3%ADsticas%20%C3%89tnico-Raciais%20da%20Popula%C3%A7%C3%A3o%20Brasileira.pdf
• ²³
  Pescarini JM, Teixeira CSS, Silva NBD, Sanchez MN, Natividade MSD, Rodrigues LC, et al. Epidemiological characteristics and temporal trends of new leprosy cases in Brazil: 2006 to 2017. Cad Saúde Publica. 2021;37:e00130020.
• ²⁴
  Azevedo YP, Bispo VAS, Oliveira RI, Gondim BB, Santos SD, da Natividade MS, et al. Epidemiological profile and spatial distribution of leprosy in Paulo Afonso, Bahia. Rev Baiana Enferm. 2021;35:e37805.
• ²⁵
  Silva ME, de Souza CD, Costa e Silva SP, Costa FM, Carmo RF. Epidemiological aspects of leprosy in Juazeiro-BA, from 2002 to 2012. An Bras Dermatol. 2015;90:799-805.
• ²⁶
  Diniz LM, Maciel LB. Leprosy: clinical and epidemiological study in patients above 60 years in Espírito Santo State - Brazil. An Bras Dermatol. 2018;93:8248.
• ²⁷
  Ramos ACV, Gomes D, Santos Neto M, Berra TZ, de Assis IS, Yamamura M, et al. Trends and forecasts of leprosy for a hyperendemic city from Brazil's northeast: Evidence from an eleven-year time-series analysis. PLoS One 2020;15:e0237165.
• ²⁸
  Soares GAV, Marinho LTM, Dias AO, Tolstenko NL, Evangelista ATM. Epidemiological profile of leprosy in a hyperendemic municipality in northeastern Brazil. Rev Cubana Enfermer. 2017;33:124-37.
• ²⁹
  Goulart IMB, Arbex GL, Carneiro MH, Rodrigues MS, Gadia R. Adverse effects of multidrug therapy in leprosy patients: a five-year survey at a Health Center at the Federal University of Uberlândia. Rev Soc Bras Med Trop. 2002;35:453-60.
• ³⁰
  Tortelly VD, Daxbaccher EL, Brotas AM, Carneiro S. Adverse effects of polychemotherapy for leprosy in 13 years of follow-up at a university hospital. An Bras Dermatol 2021;96:224-7.
• ³¹
  Cruz RCDS, Bührer-Sékula S, Penna GO, Moraes MEA, Gonçalves HS, Stefani MMA et al. Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach. An Bras Dermatol. 2018;93:377-84.
• ³²
  Sales AM, de Leon AP, Düppre NC, Hacker MA, Nery JAC, Sarno EN et al. Leprosy among Patient Contacts: A Multilevel Study of Risk Factors. PLoS Negl Trop Dis. 2011;5:e1013.
• ³³
  Durães SMB, Guedes LS, da Cunha MD, Cavaliere FAM, de Oliveira MLWDR. Study of 20 familial outbreaks of leprosy in the municipality of Duque de Caxias, Rio de Janeiro. An Bras Dermatol. 2005;80:S295-S300.
• ³⁴
  Cavalcanti AAL, Lucena-Silva N, Montarroyos UR, de Albuquerque PMCC. Concordance between expected and observed bacilloscopy results of clinical forms of leprosy: a 6-year retrospective study in Recife, State of Pernambuco, Brazil. Rev Soc Bras Med Trop. 2012;45:616-9.
• ³⁵
  Souza CDF, Paiva JPS, Leal TC, Urashima GS. Leprosy in Brazil in the 21st century: analysis of epidemiological and operational indicators using inflection point regression. An Bras Dermatol. 2020;95:743-7.
• ³⁶
  Sarkar J, Dasgupta A, Dutt D. Disability among new leprosy patients, an issue of concern: an institution based study in an endemic district for leprosy in the state of West Bengal, India. Indian J Dermatol Venereol Leprol. 2012;78:328-34.
• ³⁷
  Souza CD, Santos FG, Leal TC, Paiva JP. Trend of leprosy detection rate in Brazil, 1990 to 2016. An Bras Dermatol. 2019;94:603-7.
• ³⁸
  Guerrero MI, Muvdi S, León CI. Delay in leprosy diagnosis as a predictor of disability in a cohort of patients in Colombia, 2000-2010. Rev Panam Salud Publica. 2013;33:137-43.
• ³⁹
  de Paula HL, de Souza CDF, Silva SR, Martins-Filho PRS, Barreto JG, Gurgel RQ et al. Risk Factors for Physical Disability in Patients With Leprosy: A Systematic Review and Meta-analysis. JAMA Dermatol 2019;155:1120-8.
• ⁴⁰
  Zhang QP, Li G, Li C, Lin ZX, Chen P. Epidemiological situation of leprosy in a province in China: a long time to diagnosis and a high rate of deformity. BMC Public Health. 2020;20:1790.
• ⁴¹
  Santos MASD, Mercadante LM, Pegas ES, Kadunc BV. Relationship between bacilloscopy and operational classification of Hansen's disease in patients with reactions. An Bras Dermatol. 2018;93:454-6.
• ⁴²
  Corrêa RG, Aquino DM, Caldas AJ, Amaral DK, França FS, Mesquita ER. Epidemiological, clinical, and operational aspects of leprosy patients assisted at a referral service in the state of Maranhão, Brazil. Rev Soc Bras Med Trop. 2012;45:89-94.

Publication Dates

• Publication in this collection
  28 Aug 2023
• Date of issue
  Sep-Oct 2023

History

• Received
  16 Feb 2022
• Accepted
  31 Aug 2022
• Published
  27 Apr 2023